{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:18Z","timestamp":1759464618833,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1053\/j.ajkd.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T16:44:57Z","timestamp":1659372297000},"page":"433-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prednisone for Steroid-Sensitive Nephrotic Syndrome: Can We Use Lower Doses for the First Presentation in Children?"],"prefix":"10.1053","volume":"80","author":[{"given":"Elisabeth","family":"Hodson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2022.05.005_bib1","first-page":"239","article-title":"Report of the international study of kidney disease in children","volume":"95","year":"1979","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1053\/j.ajkd.2022.05.005_bib2","first-page":"229","article-title":"A\u00a0report of \u201cArbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie.\u201d","volume":"135","year":"1981","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1053\/j.ajkd.2022.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001533.pub4","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"9128","key":"10.1053\/j.ajkd.2022.05.005_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.005_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.005_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A\u00a0multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2022.05.005_bib7","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.005_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"issue":"4S","key":"10.1053\/j.ajkd.2022.05.005_bib9","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2022.05.005_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00431-019-03506-5","article-title":"Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study","volume":"179","author":"Borovitz","year":"2020","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1053\/j.ajkd.2022.05.005_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2215\/CJN.06140420","article-title":"Short-duration prednisolone in children with nephrotic syndrome relapse: a noninferiority randomized controlled trial","volume":"16","author":"Kainth","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2022.05.005_bib12","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00467-021-05048-1","article-title":"Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial","volume":"36","author":"Sheikh","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.005_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00467-016-3458-6","article-title":"Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children","volume":"32","author":"Raja","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2022.05.005_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00467-018-3975-6","article-title":"Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?","volume":"33","author":"Sibley","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2022.05.005_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2022.04.007","article-title":"A clinical response-adjusted steroid treatment protocol for children with newly diagnosed idiopathic nephrotic syndrome","volume":"80","author":"Zion","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2022.05.005_bib16","first-page":"163","article-title":"KDIGO Clinical Practice Guidelines for Glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:44:17Z","timestamp":1759463057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638622007429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0272638622007429"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.005","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prednisone for Steroid-Sensitive Nephrotic Syndrome: Can We Use Lower Doses for the First Presentation in Children?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}